Similar sites
Category
Biotechnology and PharmaceuticalsGlobal Rank
N/ARank in 1 month
2.4KEstimate Value
N/ASorry. Description is not currently available
#stroke
#paxlovid
#health
#health care
#senior health
#health wellness
#pharmaceutical
#pharmaceutical companies
#medicine
#pfizer
Category
N/AGlobal Rank
N/ARank in 1 month
0Estimate Value
N/A
#pfizer
#pfizer api
#pfizer kalamazoo
#pfizer manufacturing locations
#hormone api manufacturer
#biontech manufacturing gmbh
#biontech website
#pfizer customer service
#pfizer vaccine
#pfizer uk
#dalacin t pfizer
#phizer
#pfizer grants
#pfizer grange castle
#pfizer ireland
#pfizer innovation
#hospira
#pfizer hospital products
#hospira inc
#pfizer injectables
#pfizer hospital business unit
#pfizer oral
#pfizer logo
#pfizer centreone
#small molecule api
Category
PharmacyGlobal Rank
N/ARank in 1 month
14.6KEstimate Value
N/A
#health care
#health
#professional
#patient education
#medical
#patient
#professionals
#products
Category
N/AGlobal Rank
N/ARank in 1 month
0Estimate Value
N/A
#pfizer ireland
#phizer
#pfizer innovation
#bijwerkingen pfizer
#trombose
#poepen
#pfizer
#pfizer puurs
#vaccin pfizer
Category
N/AGlobal Rank
N/ARank in 1 month
0Estimate Value
N/A
#hospira
#pfizer hospital products
#hospira inc
#pfizer injectables
#pfizer hospital business unit
#oncology products suppliers
#oncology products supplier
#getwell
#health biotech
#health biotech limited
#pharmaceutical products
#telura tablet
#indmed
#heptavir 150mg tablet uses
#heptavir 150mg tablet
#alzumab injection
#zuvius lifesciences pvt ltd
#oncology formulation manufacturers in india
#hospira inc.
#pfizer logo
#pfizer products
Malware Scan Info
Macafee Check : 
Email address with pfizer-biosimilar.jp
Recent Searched Sites
Google.nl (7 seconds ago) / US
Caidesio.net (2 mins ago) / IT
Bakeforhappykids.com (35 seconds ago) / US
Jpkirk.cat (1 mins ago) / ES
Viencodien.vnua.edu.vn (24 seconds ago) / VN
Felicesvacaciones.es (29 seconds ago) / FR
Vibgyorchemical.com (1 mins ago) / US
Winxdvd.com (19 seconds ago) / US
Univ-lille1.fr (14 seconds ago) /
Toefl.givemesomeenglish.com (51 seconds ago) / US
Mannco.store (6 seconds ago) / US
Opulencespraytan.com (2 seconds ago) / US
Scitube.io (34 seconds ago) / GB
Mitsui-garden-hotel-kyoto-station.booked.jp (54 seconds ago) / US
Confectionperfection.co.uk (31 seconds ago) / US
Pfizer-biosimilar.jp (1 seconds ago) / US
Jessronagrooming.com (1 mins ago) / US
Konisastudio.com (1 mins ago) / US
Realchainedheroes.com (54 seconds ago) / DE
Gitlab.ilabt.imec.be (22 seconds ago) / BE
Domain Informations
Network
- inetnum : 104.16.0.0 - 104.31.255.255
- name : CLOUDFLARENET
- handle : NET-104-16-0-0-1
- status : Direct Allocation
- created : 2010-07-09
- changed : 2021-07-01
- desc : All Cloudflare abuse reporting can be done via https://www.cloudflare.com/abuse
Owner
- organization : Cloudflare, Inc.
- handle : CLOUD14
- address : Array,San Francisco,CA,94107,US
Abuse
- handle : ABUSE2916-ARIN
- name : Abuse
- phone : +1-650-319-8930
- email : [email protected]
Technical support
- handle : ADMIN2521-ARIN
- name : Admin
- phone : +1-650-319-8930
- email : [email protected]
| Domain Provider | Number Of Domains |
|---|---|
| godaddy.com | 680399 |
| namecheap.com | 224489 |
| networksolutions.com | 166122 |
| tucows.com | 137881 |
| publicdomainregistry.com | 88119 |
| whois.godaddy.com | 62267 |
| enomdomains.com | 58221 |
| cloudflare.com | 49364 |
| namesilo.com | 48894 |
| gmo.jp | 46192 |
| register.com | 39024 |
| fastdomain.com | 38301 |
| ionos.com | 33869 |
| name.com | 32288 |
| wildwestdomains.com | 32212 |
| net.cn | 31018 |
| registrar.amazon.com | 30344 |
| dynadot.com | 27920 |
| key-systems.net | 27185 |
Host Informations
| Host name | 104.18.34.233 |
| IP address | 104.18.34.233 |
| Location | United States |
| Latitude | 37.751 |
| Longitude | -97.822 |
| Timezone | America/Chicago |
Port Scanner (IP: 104.18.34.233)
Spam Check (IP: 104.18.34.233) › Dnsbl-1.uceprotect.net:
› Dnsbl-2.uceprotect.net:
› Dnsbl-3.uceprotect.net:
› Dnsbl.dronebl.org:
› Dnsbl.sorbs.net:
› Spam.dnsbl.sorbs.net:
› Bl.spamcop.net:
› Recent.dnsbl.sorbs.net:
› All.spamrats.com:
› B.barracudacentral.org:
› Bl.blocklist.de:
› Bl.emailbasura.org:
› Bl.mailspike.org:
› Bl.spamcop.net:
› Cblplus.anti-spam.org.cn:
› Dnsbl.anticaptcha.net:
› Ip.v4bl.org:
› Fnrbl.fast.net:
› Dnsrbl.swinog.ch:
› Mail-abuse.blacklist.jippg.org:
› Singlebl.spamgrouper.com:
› Spam.abuse.ch:
› Spamsources.fabel.dk:
› Virbl.dnsbl.bit.nl:
› Cbl.abuseat.org:
› Dnsbl.justspam.org:
› Zen.spamhaus.org:
Keyword Suggestion
Site Inspections
Websites Listing
We found Websites Listing below when search with pfizer-biosimilar.jp on Search Engine
Pfizer-バイオシミラー.jp：バイオシミラー情報サイト｜ファイザー
Pfizer-バイオシミラー.jp：バイオシミラー情報サイト｜ファイザー. バイオシミラー. とは？. なぜバイオ. シミラー？. 経済的負担を. 軽くしたい. バイオシミラーという、. もうひとつの選択肢.
Pfizer-biosimilar.jpDA: 24 PA: 24 MOZ Rank: 25
バイオシミラーとは？ - Pfizer-バイオシミラー.jp｜ファ …
バイオシミラーとは？. バイオシミラーとは、国内ですでに使われている バイオ医薬品 （以下先行バイオ医薬品）の特許期間が終了したあとに、先行バイオ医薬品と 同じような品質、安全性、有効性が確認されたバイオ医薬品 として、別の製薬会社が厚生 ...
Pfizer-biosimilar.jpDA: 24 PA: 15 MOZ Rank: 40
Understanding Biosimilars | Pfizer Canada
Pfizer’s commitment to biosimilars. As part of its commitment to delivering the highest value of care to patients, Pfizer is applying its significant resources and proven ability to meet the world’s health care challenges to develop and deliver high-quality biosimilars. In fact, Pfizer has nearly a decade of experience bringing biosimilar biologics to patients around the world. Pfizer has ...
Pfizer.caDA: 13 PA: 26 MOZ Rank: 41
Pfizer and Teva Provide a Look at Their Biosimilar …
During the first day of the 37th Annual J.P. Morgan Healthcare Conference, held January 7-10 in San Francisco, California, 2 major biosimilar developers gave a look at their strategies for 2019 and beyond. Pfizer Hints at 2019 Blockbusters, Including 4-Product “Biosimilar Bundle”
Centerforbiosimilars.comDA: 28 PA: 50 MOZ Rank: 47
Pfizer Inc. - Investor Relations - Events & Presentations
Forward-Looking Statements of Pfizer Inc. This transcript may contain forward-looking statements about, among other things, our anticipated operating and financial performance, business plans and prospects; expectations for our product pipeline, in-line products and product candidates, including anticipated regulatory submissions, data read-outs, study …
Investors.pfizer.comDA: 20 PA: 45 MOZ Rank: 69
Pfizer Breaks With Biosimilars In China Through WuXi Bio Deal
Pfizer has made the “difficult decision” to draw a line under its biosimilar endeavors in China, agreeing to sell its biologics manufacturing site in Hangzhou to local biologics contract development and manufacturing firm WuXi Biologics and halt its biosimilar programs in the country. The agreement, which is expected to close in the first ...
Pharmaintelligence.informa.comDA: 30 PA: 50 MOZ Rank: 45
Evolving U.S. Biosimilars Landscape - Syneos Health
Biosimilars (e.g., Amgen, Novartis and Pfizer). This creates an opportunity to leverage Medical Affairs functions to drive biosimilar evidence generation strategy, including: • Understanding stakeholder evidence requirements, which are unique for biosimilars • Ensuring that evidence generated is sufficient to satisfy stakeholder requirements • Driving key aspects of the …
Syneoshealth.comDA: 20 PA: 50 MOZ Rank: 44
Coherus, Pfizer, and Teva Look to Year Ahead at J.P. Morgan …
On the first day of the 36th Annual J.P. Morgan Healthcare Conference, biosimilar developers Coherus, Pfizer, and Teva all laid out their strategies for the year ahead. Cohreus Has “Very Good Reason to be Optimistic” About Pegfilgrastim Biosimilar. Coherus’ CEO, Dennis Lanfear, highlighted his company’s progress on CHS-1701, a proposed pegfilgrastim …
Centerforbiosimilars.comDA: 28 PA: 50 MOZ Rank: 43
Failure to Launch: Biosimilar Sales Continue to Fall Flat in the …
Meanwhile, the issue has been taken up in court; a lawsuit initiated in 2017 by Pfizer, maker of biosimilar infliximab, against Johnson & Johnson, maker of originator infliximab, addressing anti-competitive practices like rebate traps is ongoing. In light of multiple policy failures, one area where policy has successfully leveled the playing field for biosimilars is the Medicare Part D ...
Ncbi.nlm.nih.govDA: 20 PA: 25 MOZ Rank: 53
Pierre Gaudreault - President, Asia Region, Pfizer ... - LinkedIn
Pfizer is proud to be named one of the World’s Most Ethical Companies by Ethisphere , a global leader in defining and advancing standards for ethical… Liked by Pierre Gaudreault. La brecha de género en el ámbito profesional ha sido una barrera histórica a la que todas las mujeres nos hemos enfrentado. Sin embargo, nuestra… La brecha de género en el …
Sg.linkedin.comDA: 15 PA: 20 MOZ Rank: 44
JPM 2019: Lilly buys Loxo, Pfizer’s biosimilar bundle and $22 coffee
JPM 2019: Lilly buys Loxo, Pfizer’s biosimilar bundle and $22 coffee. by Dan Stanton Thursday, January 10, 2019 3:52 am. The 37 th JP Morgan Healthcare Conference took place this week. If the extortionate hotel prices kept you away, then BioProcess Insider you some of the highlights from San Francisco. It’s that time of year again where investors and …
Bioprocessintl.comDA: 18 PA: 50 MOZ Rank: 40
Infliximab Biosimilar for Intravenous Drip Infusion 100 mg "Pfizer ...
<Psoriasis> The usual dose is 5 mg as Infliximab (Genetical Recombination) [Infliximab Biosimilar 3] for every kg of body weight given as an intravenous infusion. After an initial dose is given, the subsequent doses are given at Weeks 2 and 6, and every 8 weeks thereafter. After a dose at Week 6 is given, the dose may be increased or the dosing interval …
Clinicaltrials.govDA: 22 PA: 21 MOZ Rank: 54
Biosimilar Price Wars: Pfizer's Biosimilar to Remicade Will Be
Biosimilars are still in an infant stage in the US healthcare market, and patients and physicians remain wary about using them. According to a …
Ajmc.comDA: 12 PA: 50 MOZ Rank: 98
Analysis on Japan's Biosimilars Landscape, 2020 - In the
Contact Data CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For ...
Globenewswire.comDA: 21 PA: 50 MOZ Rank: 37
Barriers to biosimilar utilization in the United States
Pfizer 7/20/2018 10/2018 ... Barriers to Biosimilar Utilization After Market Launch Lack of insurance coverage for biosimilar agents Improve reimbursement policies to promote use of biosimilars Medicare part B incentivizes biosimilar use by reimbursing each biosimilar at average sales price of the reference biologic plus 6%. However, Medicare could implement …
Academic.oup.comDA: 16 PA: 41 MOZ Rank: 71
Domains Expiration Date Updated
| Site | Provider | Expiration Date |
|---|---|---|
| junkmantulsa.com | tucows.com | 128 Days |